PT1001760E - Composicao para controlar disturbios de humor em individuos saudaveis - Google Patents

Composicao para controlar disturbios de humor em individuos saudaveis

Info

Publication number
PT1001760E
PT1001760E PT98929625T PT98929625T PT1001760E PT 1001760 E PT1001760 E PT 1001760E PT 98929625 T PT98929625 T PT 98929625T PT 98929625 T PT98929625 T PT 98929625T PT 1001760 E PT1001760 E PT 1001760E
Authority
PT
Portugal
Prior art keywords
composition
disturbles
healthy individuals
control human
carnitine
Prior art date
Application number
PT98929625T
Other languages
English (en)
Portuguese (pt)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PT1001760E publication Critical patent/PT1001760E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT98929625T 1997-06-18 1998-06-12 Composicao para controlar disturbios de humor em individuos saudaveis PT1001760E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000365A IT1291930B1 (it) 1997-06-18 1997-06-18 Composizione riequilibratrice delle turbe dell'umore in individui sani

Publications (1)

Publication Number Publication Date
PT1001760E true PT1001760E (pt) 2005-04-29

Family

ID=11405131

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98929625T PT1001760E (pt) 1997-06-18 1998-06-12 Composicao para controlar disturbios de humor em individuos saudaveis

Country Status (13)

Country Link
US (1) US6335021B1 (esLanguage)
EP (1) EP1001760B1 (esLanguage)
JP (1) JP2002505681A (esLanguage)
KR (1) KR20010013887A (esLanguage)
AT (1) ATE288265T1 (esLanguage)
AU (1) AU7930498A (esLanguage)
CA (1) CA2294589A1 (esLanguage)
DE (1) DE69828881T2 (esLanguage)
DK (1) DK1001760T3 (esLanguage)
ES (1) ES2236910T3 (esLanguage)
IT (1) IT1291930B1 (esLanguage)
PT (1) PT1001760E (esLanguage)
WO (1) WO1998057629A1 (esLanguage)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806307B1 (fr) * 2000-03-20 2002-11-15 Mane Fils V Preparation parfumee solide sous forme de microbilles et utilisation de ladite preparation
AU2002245588A1 (en) * 2001-03-04 2002-09-19 Sterling Medivations, Inc. Infusion hub assembly and fluid line disconnect system
JP2004532867A (ja) * 2001-05-29 2004-10-28 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 性快感消失症の治療用薬物の調製のためのアルカノイルｌ−カルニチンの使用
US7407778B2 (en) * 2002-02-07 2008-08-05 Pettegrew Jay W Compounds, compositions and methods for treating neuropsychiatric disorders
US20050272812A1 (en) * 2002-02-07 2005-12-08 Pettegrew Jay W Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans
US7700074B2 (en) * 2002-02-07 2010-04-20 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
US20040071681A1 (en) * 2002-10-10 2004-04-15 Lydia Muller Method and composition for reducing cravings for a craved substance
WO2004110963A2 (en) * 2003-05-29 2004-12-23 Pettegrew Jay W Glycerophosphocholine and its derivatives for medical imaging neuropsychiatric disorders
US20060257842A1 (en) * 2003-05-29 2006-11-16 Pettegrew Jay W Cryopreservation media and molecules
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
JP2006137746A (ja) * 2004-10-13 2006-06-01 Otsuka Pharmaceut Factory Inc オレキシン誘導組成物
US20070015518A1 (en) * 2005-07-15 2007-01-18 Agilis Systems, Inc. Mobile resource location-based customer contact systems
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US20080210748A1 (en) * 2005-11-30 2008-09-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware, Systems and methods for receiving pathogen related information and responding
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US7927787B2 (en) * 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
KR20130089158A (ko) 2010-06-16 2013-08-09 시구마-토우인더스트리에파아마슈우티히리유니트에스.피이.에이. 신경 조직에서 신경발생을 증가시키기 위한 방법에 사용하기 위한 아세틸-카르니틴
MX2022012693A (es) 2020-05-15 2022-11-07 Alfasigma Spa Composicion que comprende metilfolato.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0340759A1 (en) * 1988-05-06 1989-11-08 MAGIS FARMACEUTICI S.p.A. Salts of O-mono (di)-acetyl-glycero-mono-(bis)-(di)-phosphates of L-acetyl-carnitine and of L-acetyl carnitine esters
JP3942207B2 (ja) * 1995-02-17 2007-07-11 武田薬品工業株式会社 うつ性症状改善剤
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
US6066664A (en) * 1997-06-06 2000-05-23 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for decreasing the appetite in bulimic, overweight individuals

Also Published As

Publication number Publication date
WO1998057629A1 (en) 1998-12-23
AU7930498A (en) 1999-01-04
ITRM970365A0 (esLanguage) 1997-06-18
IT1291930B1 (it) 1999-01-21
DE69828881T2 (de) 2006-01-19
CA2294589A1 (en) 1998-12-23
DE69828881D1 (de) 2005-03-10
EP1001760B1 (en) 2005-02-02
JP2002505681A (ja) 2002-02-19
ES2236910T3 (es) 2005-07-16
KR20010013887A (ko) 2001-02-26
ITRM970365A1 (it) 1998-12-18
EP1001760A1 (en) 2000-05-24
DK1001760T3 (da) 2005-05-23
US6335021B1 (en) 2002-01-01
ATE288265T1 (de) 2005-02-15

Similar Documents

Publication Publication Date Title
PT1001760E (pt) Composicao para controlar disturbios de humor em individuos saudaveis
BR9908222A (pt) Composições para regular a aparência da pele
BR0316438A (pt) Uso de eritropoietina em doenças cardìacas
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
FI102245B1 (fi) Terveysside varustettuna sivusuuntaisilla laajentuvilla välineillä kiinnitystä varten käyttäjän alusvaatteeseen
PT1066036E (pt) Agentes com actividade relacionada com serotonina para o tratamento da apneia do sono
ES2148486T3 (es) Intermediarios de cloropirimidina.
NO970722D0 (no) Sammensatt sanitetsbind med anatomisk fasong
HUP0003381A3 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
FI962828L (fi) Monometasonifuroaatin käyttö ilmantiehye- ja keuhkosairauksien hoitamiseksi
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
EP1539137A4 (en) PPAR ALPHA SELECTIVE COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS
ID28441A (id) Terapi untuk memperbaiki kesadaran
NO995245L (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
ATE219073T1 (de) Benzopyran derivate mit leukotrien- antagonistischer wirkung
FR2720643B1 (fr) Préparation cosmétique destinée à l'amélioration esthétique du revêtement cutané par élimination des cornéocytes.
EP1287019A4 (en) THERAPEUTIC APPROACHES TO DISEASES BY SUPPRESSION OF THE NURR SUBFAMILY OF NUCLEAR TRANSCRIPTION FACTORS
NO995231D0 (no) Terapeutisk behandling av hudlidelser
MX9703810A (es) Medicamento que comprende un derivado de carnitinapara tratar la enfermedad de alzheimer en pacientes con inicio prematuro.
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
EP1575548A4 (en) COMPOSITIONS AND PROCEDURES FOR PROMOTING NEURONAL GROWTH
BR9510162A (pt) Medicamento para influenciar afecções da formação óssea
ES2188742T3 (es) Trapidil para uso en la terapia de cuadros patologicos influenciables por la inmunomodulacion.
BR9909868A (pt) Ascorbato de paroxetina